Published in Cancer Weekly, April 12th, 2005
As early as 1865, doctors observed that certain blood clotting disorders serve as warning signs of occult malignancies (which lack easily detectable symptoms), but the molecules underlying this association were unknown.
Now Carla Boccaccio and her colleagues from the Institute for Cancer Research and Treatment, Torino, Italy reported in Nature that the human cancer-causing MET gene triggers both tumor development and blood clotting problems in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.